Moreover, a Fusobacterium nucleatum (Fn)-binding M13 phage coated with silver nanoparticles was developed to target Fn in colorectal cancer, which improved mouse survival in an orthotopic colorectal cancer (CRC) model [235]. This evidence concerns the gene FN1 and colorectal cancer.